CRD-BP as a potential prognostic marker and therapeutic target in melanoma

被引：0
|
作者：
Xu, Y. G. [1 ]
Kim, T. [1 ,2 ]
Setaluri, V. [1 ]
Spiegelman, V. [1 ,3 ]
机构：
[1] Univ Wisconsin, Dermatol, Madison, WI USA
[2] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA
[3] Penn State Univ, Dept Pediat, Hershey, PA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2016年 / 136卷 / 05期
关键词：
D O I：
10.1016/j.jid.2016.02.663
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
623
引用
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [1] CRD-BP as a Tumor Marker of Colorectal Cancer
    Fen-Xu
    Jiang, Liang-Hong
    Chen-Fu
    Feng, Wei-Wei
    Zhou, Chang-Jiang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (03) : 169 - 176
  • [2] CRD-BP/IMP1 EXPRESSION AND ITS PROGNOSTIC POTENTIAL IN COLORECTAL CARCINOMAS
    Milatos, Stavros
    Dimitriadis, Euthymios
    Bardi, Georgia
    Heim, Sverre
    Johansson, Bertil
    Pandis, Nikos
    Trangas, Theoni
    Ioannidis, Panayotis
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3522 - 3523
  • [3] Pannexin: potential new target and prognostic marker for melanoma
    Lake, Francesca
    FUTURE ONCOLOGY, 2012, 8 (10) : 1221 - 1221
  • [4] Pannexin: potential new target and prognostic marker for melanoma
    Lake, Francesca
    EXPERT REVIEW OF PROTEOMICS, 2012, 9 (05) : 483 - 483
  • [5] Pannexin is a potential new target and prognostic marker for melanoma
    Lake, Francesca
    BIOMARKERS IN MEDICINE, 2012, 6 (05) : 638 - 638
  • [6] Pannexin: a potential new target and prognostic marker for melanoma
    Lake, Francesca
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1250 - 1250
  • [7] Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions
    Dundr, Pavel
    Simon, Karol
    Nemejcova, Kristyna
    Bartu, Michaela
    Ticha, Ivana
    Michalkova, Romana
    Jaksa, Radek
    Veckova, Zuzana
    Kodet, Ondrej
    MELANOMA RESEARCH, 2019, 29 (02) : 157 - 162
  • [8] Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia
    Craig, Evisabel A.
    Weber, Jonathan D.
    Spiegelman, Vladimir S.
    JOURNAL OF CELL SCIENCE, 2012, 125 (24) : 5950 - 5954
  • [9] Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
    Gronberg, Malin
    Ahlin, Cecilia
    Naeser, Ylva
    Janson, Eva Tiensuu
    Holmberg, Lars
    Fjallskog, Marie-Louise
    PLOS ONE, 2017, 12 (04):
  • [10] Overexpression of mRNA-binding protein CRD-BP in malignant melanomas
    Elcheva, I.
    Tarapore, R.
    Bhatia, N.
    Spiegelman, V. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S214 - S214
12345